(Alain Jocard/AFP/Getty Images) Every year, more than 2 million people in the United States are diagnosed with ...
The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.